The pharmaceutical world is seeing a significant shift in glucose management with the emergence of GLP-1 skin applications. These patches offer a seemingly more convenient alternative to subcutaneous administrations of GLP-1 drugs, reducing the frequency of daily needle pricks. The approach admin